[Skip to Content]
[Skip to Content Landing]
Views 397
Citations 0
Comment & Response
June 24, 2020

Evaluation of the Merits and Limitations of Evidence-Based Medicine

Author Affiliations
  • 1Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia
  • 2Department of Dermatology, New York University School of Medicine, New York, New York
JAMA Dermatol. Published online June 24, 2020. doi:10.1001/jamadermatol.2020.1940

To the Editor Although we appreciate the efforts of Pournamdari et al1 to highlight areas of overuse in the field of dermatology, we were greatly surprised that 2 of the selected topics were reexcision of (severely) dysplastic nevi (DN) and sentinel lymph node (SLN) biopsy for cutaneous melanoma, given the limited data supporting their conclusions. Instead of a comprehensive literature review on a specific topic, the authors chose 10 articles on 6 distinct topics, drawing conclusions without the context of other existing literature. The authors gave only 1 of the 10 studies an A for quality of evidence; 5 were rated B, and 4 were rated C.1

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×